spacer

CDC HomeHIV/AIDS > Reports > HIV Prevention Strategic Plan: Extended Through 2010 > Appendix 3: 2006 CHAC Highlights of CDC Activities that Address the Goals and Objectives

spacer spacer
spacer
Skip Nav spacer
Performance Indicators (5, 6, & 7) for Goal 1 with baseline data, performance progress data, and projected targets
spacer
spacer

Indicator 5: The percentage of students in 9th through 12th grade who report they have never had sexual intercourse; or, if they have had sexual intercourse, not in the past month; or, who have had sexual intercourse in the past 3 months and used a condom. 

Baseline data, performance progress data, and projected targets: 

Year 1999 (baseline): 85.0% of 9th-12th graders had never had sexual intercourse
Year 2001 (performance): 86.1% of 9th-12th graders had never had sexual intercourse (12.2% had sex, but not in past month and 19.1% had sex in the past 3 months, but used a condom)
Year 2003 (performance): 87.5% of 9th-12th graders had never had sexual intercourse (12.3% had sex, but not in the past month, and 21.3% had sex in the past 3 months, but used a condom)
Year 2005 target: 88%
Year 2009* target: 90%

Data Source: CDC. Youth Risk Behavior Surveillance System (YRBSS)


*YRBSS is conducted in odd numbered years so there are no data for 2000 and 2002, and the target is set for 2009 rather than 2010.


Indicator 6: Among the persons diagnosed with HIV infection for >12 months and interviewed in SHAS,* the percentage who did not use a condom at last vaginal/anal sex when the status of the partner was unknown.

Baseline data, performance progress data, and projected targets: 

Year 2001 (baseline): 12.3% did not use a condom at last vaginal/anal sex with a partner whose HIV status was negative or unknown
Year 2002 (performance): 13.9%
Year 2003 (performance): 17%
Year 2004 (performance): 13.4%
Year 2005 target: 10%
Year 2010 target: 8%

Data source: CDC. Supplement to HIV/AIDS Surveillance (SHAS) Project


* The Supplement to HIV/AIDS Surveillance (SHAS) project is conducted in the following states: Arizona, California, Colorado, Connecticut, Delaware, Florida, Georgia, Illinois, Kansas, Maryland, Michigan, Minnesota, New Jersey, New Mexico, South Carolina, Texas, and Washington; and the following cities: Houston and Philadelphia. CDC summarizes data from SHAS project and examines the representativeness of these data. This indicator will not be available after 2004 because CDC will discontinue this project in mid-2004. To replace SHAS, CDC is developing a more representative surveillance system for the entire HIV-infected population in the United States in mid-2004.


Indicator 7: Among persons diagnosed with HIV infection for >12 months and interviewed in SHAS,* the percent of injection drug users (IDUs) who shared a needle or syringe with someone in the past 12 months.

Year 2001 (baseline): 7%
Year 2002: 3%
Year 2003: 5%
Year 2004: 7%
Year 2005 target: 3%
Year 2010 target: 1%

Data source: CDC. Supplement to HIV/AIDS Surveillance (SHAS) Project


* The Supplement to HIV/AIDS Surveillance (SHAS) project is conducted in the following states: Arizona, California, Colorado, Connecticut, Delaware, Florida, Georgia, Illinois, Kansas, Maryland, Michigan, Minnesota, New Jersey, New Mexico, South Carolina, Texas, and Washington; and the following cities: Houston and Philadelphia. CDC summarizes data from SHAS project and examines the representativeness of these data. This indicator will not be available after 2004 because CDC will discontinue this project in mid-2004. To replace SHAS, CDC is developing a surveillance system for the entire HIV-infected population in the United States.


Go to Goal 1 Supplemental Activities

spacer
Last Modified: December 28, 2007
Last Reviewed: December 28, 2007
Content Source:
Divisions of HIV/AIDS Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
spacer
spacer
spacer
spacer
spacer CDC Black Logospacer Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, 24 Hours/Every Day - cdcinfo@cdc.gov
spacer
spacerHHS Logo